TriSalus Life Sciences, Inc. TLSI Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $8.9M-2.9% | $13.21M+59.8% | $11.57M+57.4% | $11.21M+52.3% | $9.17M+42.0% | ||
| $1.23M-17.7% | $1.76M+44.9% | $1.91M+89.8% | $1.8M+97.6% | $1.5M+54.0% | ||
| $7.67M0.0% | $11.44M+62.4% | $9.66M+52.2% | $9.41M+45.9% | $7.67M+39.8% | ||
| 86.2%+2.5pp | 86.7%+1.4pp | 83.5%-2.8pp | 83.9%-3.7pp | 83.7%-1.3pp | ||
| $3.22M+6.5% | $2.57M-13.1% | $5.18M+22.7% | $3.92M-15.9% | $3.02M-48.3% | ||
| $7.41M+10.1% | $7.97M+13.7% | $6.84M+11.4% | $7.16M+19.3% | $6.73M+0.7% | ||
| $5.45M+3.9% | $4.17M-10.4% | $6.66M+40.9% | $5.66M+43.0% | $5.25M+13.4% | ||
| -$8.41M-14.8% | -$3.27M+56.8% | -$9.01M-3.1% | -$7.33M+10.3% | -$7.33M+37.2% | ||
| -94.5%-14.6pp | -24.8%+67.0pp | -77.9%+41.0pp | -65.4%+45.6pp | -79.9%+101pp | ||
| $1.44M+18.8% | $1.45M+36.0% | $1.46M+27.8% | $1.42M+62.3% | $1.21M+40,200% | ||
| -$76K+69.7% | -$71K+30.4% | -$94K-623% | -$40K+9.1% | -$251K-64.1% | ||
| $1.54M+115% | -$9.75M+3.5% | -$10.81M-350% | -$8.29M-91.7% | -$10.37M+21.5% | ||
| $4K-20.0% | $0— | $5K+267% | -$3K-143% | $5K+66.7% | ||
| $1.54M+115% | -$9.75M+3.5% | -$10.81M-351% | -$8.29M-91.3% | -$10.38M+21.4% | ||
| 17.3%+130pp | -73.9%+48.5pp | -93.5%-60.8pp | -73.9%-15.1pp | -113.2%+91.3pp | ||
| $0-100% | $0-100% | $0-100% | $714K-10.9% | $712K-11.1% | ||
| $0.03+108% | -$0.12+70.0% | -$0.96-700% | -$0.27-28.6% | -$0.39+35.0% | ||
| $0.03+108% | -$0.12+70.0% | -$0.96-700% | -$0.27-28.6% | -$0.39+35.0% | ||
| 52.3M+83.4% | 37.9M+49.6% | 43.1M+62.5% | 32.9M+37.6% | 28.5M+22.3% | ||
| 51.5M+80.7% | 37.9M+49.6% | 43.1M+62.5% | 32.9M+37.6% | 28.5M+22.3% | ||
| -$7.4M-1,003% | $5.15M— | -$2.52M-6.9% | -$700K+94.9% | $820K-79.4% | ||
| $3.9M+567% | $0+100% | -$2.79M— | -$477K+94.9% | -$835K-133% | ||
| $3.9M+567% | $0+100% | -$2.93M-159% | -$330K+96.3% | -$835K-133% | ||
| -$76K+69.7% | -$71K+30.4% | -$94K-623% | -$40K+9.1% | -$251K-64.1% | ||
| $8.9M-2.9% | $13.21M+59.8% | $11.57M+57.4% | $11.21M+52.3% | $9.17M+42.0% | ||
| -$8.41M-14.8% | -$3.27M+56.8% | -$9.01M-3.1% | -$7.33M+10.3% | -$7.33M+37.2% | ||
| -$8.28M-15.6% | -$3.15M+57.4% | -$8.85M-3.4% | -$7.17M+10.2% | -$7.16M+37.7% | ||
| -$8.28M-15.6% | -$3.15M+57.4% | -$8.85M-3.4% | -$7.17M+10.2% | -$7.16M+37.7% | ||
| -93%-14.9pp | -23.8%+65.6pp | -76.5%+39.9pp | -63.9%+44.4pp | -78.1%+100.0pp | ||
| -$8.41M-14.8% | -$3.27M+56.8% | -$9.01M-3.1% | -$7.33M+10.3% | -$7.33M+37.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is TriSalus Life Sciences, Inc.'s revenue?
- TriSalus Life Sciences, Inc. (TLSI) generated $44.9M in revenue over the trailing twelve months, up 39.6% year over year.
- Is TriSalus Life Sciences, Inc. profitable?
- TriSalus Life Sciences, Inc. is not currently profitable: it reported a net loss of $27.3M over the trailing twelve months, a -60.9% net margin.
- What are TriSalus Life Sciences, Inc.'s profit margins?
- Gross margin is 85.1% and operating margin is -62.4%, with a -60.9% net margin.
- What is TriSalus Life Sciences, Inc.'s earnings per share?
- TriSalus Life Sciences, Inc.'s diluted EPS over the trailing twelve months is $-1.32.
- Where does TriSalus Life Sciences, Inc.'s income statement data come from?
- Every line is extracted from TriSalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
